Advertisement

Topics

Companies Related to "Apomorphine Injection Parkinson Disease" [Most Relevant Company Matches] - Page: 3 [Advanced Search Results] RSS

05:01 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Apomorphine Injection Parkinson Disease" found in our extensive corporate database of over 50,000 company records.

Showing "Apomorphine Injection Parkinson Disease" Companies 51–75 of 2,800+

Relevant

Diacrin Incorporated

Diacrin is developing transplantable cells for the treatment of human diseases which are characterized by cell dysfunction or cell death and for which current therapies are either inadequate or nonexistent. Products under development for the treatment of neurological disorders include: NeuroCell(TM)-PD for Parkinson's disease and NeuroCell(TM)-HD for Huntington's dise...


AMAG Pharmaceuticals, Inc.

rPeptide, LLC

rPeptide is a biotechnology company located in Athens, Georgia, USA, and is a market leader in providing research products (recombinant peptides and proteins, antibodies, reagents) for Alzheimer's disease and Parkinson's disease research. rPeptide also provides a range of custom services from molecular biology, protein expression and purification, to 13C and 15N uniform labeling of peptides and pr...


Neurologix, Inc.

Neurologix, Inc. (OTCBB:NRGX) is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of life-altering gene transfer therapies for serious disorders of the brain and central nervous system. Neurologix’s therapeutic approach is built upon the groundbreaking research of its scientific founders and advisor...

Tigermed Consulting Co., Ltd

Tigermed Consulting Co., Ltd, a leading Contract Research Organization (CRO) in China, is expected to become the largest CRO in China within 3 years. With capital injection from Qiming Venture in 2008, Tigermed has entered into a period of rapid expansion. The combined asset injection to MacroStat marks a stride forward in Tigermed's internationalization strategic development. The extensive co...

EnVivo Pharmaceuticals

Mission: to discover and develop small-molecule therapeutics for disorders of the central nervous system (CNS), specifically neurodegenerative diseases, such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, and Spinocerebellar Ataxias.About UsEnVivo Pharmaceuticals was founded in 2001 and currently has 37 FTEs. EnVivo has raised ~$38M in two funding rounds, $14.9M Series A ...

The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein ...

Vernalis

Vernalis is a UK-based specialty pharmaceutical company with two marketed products, Apokyn® to treat immobilising "off" episodes in patients with advanced Parkinson's disease and Frova®, to treat migraine. The company has a broad development pipeline focused on neurology and central nervous system disorders.

Diagnostic Potentials Ltd

Diagnostic Potentials Ltd is developing a range of diagnostic and monitoring systems for Central Nervous system (CNS) disease states. The first product that has been developed is a system for the early diagnosis of Alzheimer's Disease that will enable clinical consultants to make a positive decision on the care of the patient and on the prescribing of drugs.CNS disorders, such as Alzheimer's, Park...

Penwest

Penwest develops pharmaceutical products based on innovative proprietary drug delivery technologies. We are focusing our development efforts principally on products that address disorders of the nervous system. Our pipeline consists of product candidates in pain, epilepsy, depression, Parkinson’s disease and edema associated with congestive heart failure.

Power3 Medical Products, Inc

Originally formed as a medical device company, Power3 Medical Products, Inc. has since transitioned to an innovative holding company strategically positioned to acquire specialty healthcare and biotechnology assets. On May 18, 2004, Power3 purchased the assets and intellectual properties of ProteEx of The Woodlands, TX. The company was founded in 2000 by two seasoned medical biotechnology veterans...

H. Lundbeck A/S

We are a research-based company. We engage in research to find new drugs for treatment of CNS disorders, includ­ing depression, schizophrenia, Alzheimer’s disease and Parkinson’s disease.These are serious disorders. They affect not only patients, but also their families and friends. Besides the stress of having a CNS disorder, patients are often exposed to prejudice because, in many sections ...

EMD Serono, Inc.

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve people's lives. The company has strong market positions in neurodegenerative diseases, with Rebif® (interferon beta-1a), as well as in endocrinology, with S...

EMD Serono

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve people's lives. The company has strong market positions in neurodegenerative diseases, with Rebif® (interferon beta-1a), as well as in endocrinology, with S...

Avid Radiopharmaceuticals, Inc.

Avid Radiopharmaceuticals is a leader in the development of molecular imaging products with the potential for earlier and more effective detection, diagnosis and monitoring of major chronic human diseases. Based in Philadelphia, PA, the company’s lead program is a molecular imaging agent for amyloid plaque that could lead to earlier detection and bett...

Addex Therapeutics

Addex Therapeutics is pioneering discovery and development of an emerging class of oral small molecule drugs, called allosteric modulators, which can be exquisitely selective for their intended target and confer significant therapeutic advantages over conventional “orthosteric” small molecule or biological drugs. The Company uses its proprietary discovery platform to address receptor...

Okanagan Clinical Trials

Here at Okanagan Clinical Trials we conduct medical studies on a variety of different conditions. Some of the illnesses we have studied to date include depression, anxiety, insomnia, diabetes, obesity, headaches, pain due to shingles, parkinson's disease and high cholesterol. Our goal is to provide a positive experience for the many patients who volunteer to participate in our trials.

Salter Labs

Medical sales, marketing and distribution worldwide Clinical trial to FDA regulatory guidelines Injection mold tool design and fabrication Injection molding, extrusion manufacturing and assembly process Quality assurance and inspection techniques honed many times over in Class II environments.

Nanna Therapeutics

Nanna Therapeutics has built a unique, game-changing Totally Integrated Medicines Engine (TIME) to create novel therapeutics. Enabled by advanced machine learning, TIME utilises its paradigm shift in the speed, efficiency and quality of drug discovery, as well as dramatically enhanced safety profiling, to improve clinical success. In addition to working wi...

Neurological Consultants, P.C.

Ideally, the senior years are a time when you are free to pursue your personal interests, to get involved in your community, and to reap the benefits of your many years of hard work. When health concerns get in your way, however, finding all the medical and other resources you need can be a complicated task. That's why Neurological Consultants developed its Geriatric Neurology Service -- to assure...

Probably Relevant

Civitas Therapeutics, Inc.

Civitas is a privately held pharmaceutical company focused on developing products with a clinically proven dry powder pulmonary delivery platform. The proprietary dry powder and device combination is unique in its ability to deliver a large, precise dose independent of inspiratory flow rate from a simple, passive device. The technology has successfully del...

AFFiRiS AG

On the basis of the company's own patents, AFFiRiS develops tailor-made peptide vaccines against Alzheimer's disease, atherosclerosis, Parkinson's disease hypertension and four other conditions with an urgent medical requirement and attractive market volumes. Alzheimer's is currently the most advanced project, with two potential products having just completed the phase I clinical studies. In O...

iZumi Bio, Inc.

iPierian is a South San Francisco-based biopharmaceutical company focused on the industrialization of induced pluripotent stem cell (iPS) technology with the mission of creating new therapeutics through cellular reprogramming and directed differentiation of patient cells. iPierian is backed by Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital. Th...

Pharma Two B Ltd.

Pharma Two B develops clinically differentiated and value-added products, based on approved drugs. The company focuses on Fixed-Dose-combinations of two or more drugs with complementary and synergistic effects, providing high clinical value and shorter regulatory pathways (US 505(b)(2) approach). The company develops products in two therapeutic areas with ...

Upsher-Smith Laboratories, Inc.

Upsher-Smith, founded in 1919, is an independent and privately-owned specialty pharmaceutical company headquartered in Maple Grove, Minnesota that focuses on product growth and innovation for branded, branded-generic and generic pharmaceuticals. Upsher-Smith has a particular focus on providing therapies to assist people suffering from central nervous syste...


More From BioPortfolio on "Apomorphine Injection Parkinson Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks